FuturedMe

Trademark usage description

chemical reagents for use in the degradation of proteins for in vitro and in vivo use; cell culture reagents for non-medical purposes; biomedical comp Read More

Classification Information

Class [001]
Chemical reagents for use in the degradation of proteins for in vitro and in vivo use; cell culture reagents for non-medical purposes; biomedical compounds, namely, polypeptides for universal masking of proteins; proteomics analysis test kits comprising reagents for detecting antibody proteins in a biological sample for scientific research purposes; diagnostic reagents for medical-scientific research use; reagents for testing the sterility of medical equipment; high purity spectroscopic solvents for spectroscopic analysis; proteomics analysis test kits comprising reagents for characterizing antibody proteins in a biological sample for scientific research purposes; proteomics analysis test kits comprising reagents for quantifying antibody proteins in a biological sample for scientific research purposes; spectroscopic solvents for laboratory spectroscopic analysis; biological assays and kits for use in fields of biological and diagnostic testing for industrial, scientific and research use; diagnostic enzymes for in vitro use in biochemistry; diagnostic enzymes for in vitro use in clinical chemistry; diagnostic enzymes for in vitro use in microbiology; diagnostic preparations for medical-scientific research use; cell growth media for growing cells for use in scientific research; stem cells for scientific purposes; chemical additives for use in enzyme stabilization; chemical additives for use in hydrothermal liquefaction processes; chemicals for use in the manufacture of solvents for laboratory analysis, other than for medical and veterinary purposes; chemical additives to insecticides; microbes as active chemical ingredients for use in the manufacture of pharmaceuticals; agricultural fertilizer; bacteria for post-harvest use in agriculture; chemicals for post-harvest use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; fertilizers, chemical products for fertilizers; plant growth hormone preparations; seed treatment chemicals for use in the manufacture of fungicides and insecticides for agricultural use; vine disease preventing chemicals; agricultural adjuvants for use with pesticides and fertilizers; biological preservatives for post-harvest use in agriculture, horticulture and forestry; biotechnologically-formed genes for use in the production of agricultural seeds to enhance plants' growth therefrom; fertilizer for agricultural use; plant growth regulating preparations; fertilizers; higher fatty acids; reagent paper for scientific or research use; artificial sweeteners

Classification kind code

Class [005]
Reagent paper for medical or veterinary purposes; reagents for use in testing proteins for medical diagnostic purposes; diagnostic reagents and agents for medical diagnostic use; diagnostic reagents for clinical laboratory use; diagnostic reagents for medical diagnostic use; diagnostic reagents for medical laboratory use; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting autoimmune diseases; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting infections; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, sepsis; diagnostic preparations and human therapeutics for medical use, namely, antisense oligonucleotides; diagnostic preparations for clinical laboratory use; diagnostic preparations for medical laboratory use; tumor suppressing agents; anti-cancer preparations; anti-sarcoma preparations; pharmaceutical preparations for use in the treatment of oncological, immunological, and central nervous system diseases and disorders; pharmaceutical preparations namely, anti-inflammatories; pharmaceutical preparations for use in the treatment of inflammatory pelvic diseases; pharmaceutical preparations for use in the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for use in the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of diseases, disorders, and conditions associated with senescence, namely osteoarthritis, ophthalmic disease, pulmonary disease, liver disease, kidney disease, Parkinson's disease, Alzheimer's disease, dementia, rheumatism, degenerative nerve diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases and osteoporosis; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the prevention and treatment of pulmonary hypertension and pulmonary arterial hypertension; neurological pharmaceutical preparations for the prevention and treatment of Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations for the treatment of type 2 diabetes; pharmaceutical preparations for use in the treatment of cataracts; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the treatment of diseases, disorders and infections of the spinal cord systems and related cartilage and tissue; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, and neuromuscular diseases, namely primary periodic paralysis; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema, and sexually transmitted diseases; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and bacterial skin infections and fungal skin infections; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for use in the treatment of infectious diseases, namely urinary tract infection, odontogenic infection and vaginal infection; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer; pharmaceutical preparations for the treatment of skin cancer; pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders; pharmaceutical preparations for the diagnosis of oncological diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of oncological diseases; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for treatment of autoimmune diseases and disorders; pharmaceutical products for the treatment of rare autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of immunological disorders; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; anti-inflammatory medications; anti-inflammatory pharmaceutical preparations; pharmaceutical anti-inflammatories; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of cancer and autoimmune diseases; pharmaceutical preparations for the treatment of oncological diseases and disorders for human use only; pharmaceutical preparations and substances for the treatment of neurological diseases and disorders for human use only, namely, neurofibromatosis; pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective; pharmaceutical preparations for human medicine for the prevention and the treatment of central nervous system disorders; medicinal preparation, namely a synthetic octapeptide analogue of naturally occurring somatostatin, inhibiting the secretion of peptides of the gastroenteropancreatic endocrine system and of growth hormone, useful in the management of gastrointestinal endocrine tumors; pharmaceutical preparations, namely medicines for human use for the regulation of the immune system; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals to treat cancer; human pharmaceutical preparations for the relief of pain; pharmaceutical preparations for diagnosing and treating neurodegenerative diseases; radioactive pharmaceutical preparations for in vivo diagnostic or therapeutic use; antiviral pharmaceutical preparations; CRISPR-based pharmaceuticals for the treatment of genetic diseases; drug delivery agents in the form of compressed gum that facilitate the delivery of pharmaceutical preparations; human pharmaceutical vaccines; human pharmaceuticals for treatment of cancer; injectable pharmaceutical contraceptives; neurological and psychological pharmaceutical preparations for the treatment of chemical dependency; pharmaceutical anti-viral agents; pharmaceutical enzymes for use as gene editor for the treatment of genetic diseases and disorders; pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the prevention and treatment of diabetes; pesticides, preparations for destroying vermin, fungicides, herbicides, insecticides; preparations for destroying and combating vermin; vermin destroying preparations; agricultural herbicides; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton; adhesive plasters; bandages for dressings; liquid bandages; breast-nursing pads; cotton swabs for medical use; dental impression materials; dental lacquer; rubber for dental purposes; alloys of precious metals for dental purposes; alloys for dental bridges and crowns; dental abrasives, dental polish; dental enamel; dental fillings; dental materials for use with 3D printers; dental materials used to produce 3D printed try-in appliances; dental moldings; dental plasters; dental restoration material; dental sealants; dental swabs; porcelain for dental prostheses; pulp capping materials for dental purposes; protein powder nutritional supplements; acai powder dietary supplements; albumin dietary supplements; amino acid dietary supplements; vitamin and protein preparations in the form of meal replacement shakes; protein powders for meal replacement for use as a dietary supplement; quinoa protein concentrates being dietary supplements; dietary supplements for enhancing the immune system; dietary supplements for promoting weight loss; dietary supplements for reducing cholesterol; dietary, nutritional and herbal supplements for general health and well-being; iron supplements; magnesium dietary supplements; mineral supplements; nutritional supplements as a sleep aid; nutritional supplements for brain development; vitamin food supplements; medicated beverages in the nature of psilocybin botanical supplements for the treatment of mental health disorders; dietetic beverages adapted for medical purposes for the treatment of gluten intolerance and celiac disease; effervescent tablets and powders used to make electrolyte replacement beverages for medical purposes; nutraceutical food and beverages for general health and well-being; nutritional supplement meal replacement beverages containing vitamins and minerals; albumen dietary supplements for medical purposes; dietary supplements for humans containing cannabinoids for medicinal purposes; dietary supplements for general health and well-being; dietary supplements for humans containing cannabis derivatives for medicinal purposes; dietary supplements for humans containing cannabis for medicinal purposes; dietary supplements for humans containing marijuana derivatives for medicinal purposes; dietary supplements for humans containing marijuana for medicinal purposes; medicated food supplements being tablets for maintaining normal blood pressure and heart function; medicated food supplements being tablets for reducing cholesterol; nutritional additives for medical purposes namely for promoting general health and well-being, used in foods and dietary supplements for human consumption; nutritional supplements for reducing stress; nutritional supplements for relief of pain; nutritional supplements to boost the immune system; beverages for babies; food for babies; protein supplements for animals; animal feed additives for use as nutritional supplements; antibiotic food supplements for animals; dietary and nutritional supplements for pets for heart health; dietary and nutritional supplements for pets for maintaining a healthy digestive system; dietary pet supplements containing cannabis in the form of pet treats and pet food; dietary supplement for animal feed containing essential oils for the maintenance of healthy digestive functions in poultry; dietary supplement for animal feed containing essential oils for the maintenance of healthy digestive functions in swine; dietary supplements for animals containing cannabinoids for medicinal purposes; dietary supplements for animals for general health and well-being; dietary supplements for animals for skin and coat health, bone and joint health, stress reduction, and digestive health; dietary supplements for animals, namely, antioxidants; dietary supplements for pets for general health and wellbeing; melatonin supplements for pets; nutritional supplements for animals to promote energy and healthy fur, paws, and claws; pet food additives in the form of vitamin and mineral; probiotic supplements for pets; veterinarian-supervised dietary pet food

Classification kind code

Class [042]
Analysis of proteins for scientific and medical research purposes; providing temporary use of non-downloadable software for the analysis of proteins; analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; chemical molecular analysis, product optimization, and clinical trial services to pharmaceutical industries; laboratory research in the field of pharmaceuticals and nutraceuticals; pharmaceutical evaluation services; cosmetic research services; laboratory research in the field of cosmetics; testing of pharmaceuticals; testing services in the field of immunopharmaceuticals; testing services in the field of vaccines; bacteriological consultation, research and testing; pharmacological research services; medical research information in the fields of pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and proteomics; providing scientific research information in the fields of pharmaceuticals; providing medical and scientific research information in the field of cosmetics and clinical trials; research and development in the fields of skin care and cosmetics; providing information in the field of food safety; providing quality control for the food industry; providing information on the prevention, screening, diagnosis and treatment of neuromuscular diseases; providing medical research information in the field of clinical trials; providing scientific research information in the field of clinical trials; providing scientific research information in the fields of biomedicine; providing scientific research information in the fields of clinical trials and post-market trials; research and development in the pharmaceutical fields; research and development in the medical biotechnology field; research and development in the industrial biotechnology field; research and development in the agricultural biotechnology field; pharmaceutical research and development services; conducting research, development, and evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines for the treatment of disorders relating to drug and chemical addictions; pharmaceutical drug development services; research and development in the pharmaceutical and proteomics fields; scientific research in the field of pharmacology, pharmaceuticals, and biochemistry; design and development of medical testing and analysis methods in the field of audiology and ophthalmology; laboratory research analysis in the field of genetic testing; dna analysis services for scientific research purposes; health inspection services; medical and pharmacological research services; medical and scientific research services in the areas of medicines and pharmaceuticals for antisense therapy; medical research in the field of brain diseases and disorders; medical research in the field of cancer treatment and diagnosis; medical research in the field of central nervous system diseases and disorders; medical research in the field of immune sequencing; medical technology development and research in the field of medical diagnostic imaging; software as a service (saas) provided for accessing medical and health information; application service provider (ASP) for searching structured and unstructured data for healthcare data analytics; biological therapeutic research services; research, development of pharmaceutical preparations; clinical trials for pharmaceuticals; quality control of pharmaceutical preparations; providing quality assurance in the field of computer software; providing quality assurance in the field of computer software quality testing; providing quality assurance in the food industry; providing quality control for the computer software development industry; testing and research on prevention of pollution; technical project studies in the field of agriculture; research and development in the field of biomass combustion for use in environmentally sustainable farming; providing technical project studies in the field of environmentally sustainable farming; preparation of reports relating to technical project studies for projects in the field of agriculture; industrial analysis and research services in the field of agriculture and horticulture; agricultural engineering; testing services for medical apparatus and instruments and their parts; calibration of laboratory equipment; research and development in the field of medical devices; design of medical apparatus and instruments; technical development of prescription drug programs designed to process claims for medical products used by consumers; conducting research, development, and evaluations in the field of dystonias, muscular dystonia, and cervical dystonia treatment; research and development of medical diagnostic assays for the testing and diagnosis of sepsis; research and design in the field of chemistry; research and design in the field of physiology; design and development of virtual reality software for use in providing online collaboration environments between medical professionals; software as a service featuring software for managing pharmaceutical and biopharmaceutical manufacturing processes; computer hardware and software integration and deployment services in the field of information security and cybersecurity; consultancy and information services in the field of computer system integration, data integration, data migration and cloud automation; consultancy services by physicians and medical researchers in the field of virtual reality software development for use in medical, healthcare and surgical training; computer diagnostic services for pharmacists and healthcare practitioners; platform as a service (PaaS) featuring computer software platforms for providing virtual medical clinic services; platform as a service (paas) offering computer software for processing and analysis of ultrasound images for medical diagnostic imaging; technological advice relating to computers, automobiles and industrial machines; rental of computers; providing non-downloadable computer software for use in quality assurance of the services of others in the field of pharmaceuticals and medical devices; providing temporary use of non-downloadable computer software for dispensing and administering pharmaceuticals and medical supplies; providing temporary use of non-downloadable computer software for supply chain and inventory management systems for pharmaceuticals and medical supplies; providing temporary use of non-downloadable computer software for connecting doctors with medical patients and providing medical information to doctors; application service provider featuring application programming interface (API) software for analyzing molecular and clinical data for scientific and medical research; rental of laboratory apparatus and instruments

Classification kind code

Class [044]
Medical and veterinary, beauty, agricultural and forestry

Comment text

CIPO Classification Code

Classification kind code

Nice

Mark Details

Serial Number

1965591

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 27 on 12^th Feb 2025	Approval Notice Sent
Submitted for opposition 15 on 20^th Aug 2024	Correspondence Created
Submitted for opposition 22 on 8^th Jan 2024	Search Recorded
Submitted for opposition 20 on 8^th Jan 2024	Examiner's First Report
Submitted for opposition 67 on 7^th Oct 2022	Agent Name Changed
Submitted for opposition 287 on 9^th May 2022	Pre-Assessment Letter Sent
Submitted for opposition 67 on 11^th Sept 2019	Agent Name Changed
Submitted for opposition 31 on 31^st May 2019	Formalized
Submitted for opposition 1 on 30^th May 2019	Created
Submitted for opposition 30 on 29^th May 2019	Filed

FuturedMe

Classification Information

Classification kind code

Classification kind code

Classification kind code

Class [044]Medical and veterinary, beauty, agricultural and forestry

Comment text

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [044]
Medical and veterinary, beauty, agricultural and forestry